ATE477331T1 - Verfahren zum nachweis einer hiv-infektion - Google Patents

Verfahren zum nachweis einer hiv-infektion

Info

Publication number
ATE477331T1
ATE477331T1 AT07756200T AT07756200T ATE477331T1 AT E477331 T1 ATE477331 T1 AT E477331T1 AT 07756200 T AT07756200 T AT 07756200T AT 07756200 T AT07756200 T AT 07756200T AT E477331 T1 ATE477331 T1 AT E477331T1
Authority
AT
Austria
Prior art keywords
hiv infection
detecting hiv
infection
hiv
afd
Prior art date
Application number
AT07756200T
Other languages
English (en)
Inventor
Yuntao Wu
Dongyang Yu
Jeremy Kelly
Rebecca Yoder
Original Assignee
George Mason Intellectual Prop
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by George Mason Intellectual Prop filed Critical George Mason Intellectual Prop
Application granted granted Critical
Publication of ATE477331T1 publication Critical patent/ATE477331T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • G01N33/56988HIV or HTLV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/42Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving phosphatase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08RNA viruses
    • G01N2333/15Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
    • G01N2333/16HIV-1, HIV-2
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/02Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
AT07756200T 2006-05-05 2007-05-04 Verfahren zum nachweis einer hiv-infektion ATE477331T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US79774506P 2006-05-05 2006-05-05
US89415007P 2007-03-09 2007-03-09
PCT/US2007/010750 WO2007130523A2 (en) 2006-05-05 2007-05-04 Compositions and methods for detecting and treating hiv infection

Publications (1)

Publication Number Publication Date
ATE477331T1 true ATE477331T1 (de) 2010-08-15

Family

ID=38624429

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07756200T ATE477331T1 (de) 2006-05-05 2007-05-04 Verfahren zum nachweis einer hiv-infektion

Country Status (6)

Country Link
US (2) US7662547B2 (de)
EP (2) EP2021496B1 (de)
AT (1) ATE477331T1 (de)
CA (1) CA2651317A1 (de)
DE (1) DE602007008398D1 (de)
WO (1) WO2007130523A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2307367T3 (pl) 2008-07-08 2015-03-31 Univ Texas Nowe inhibitory proliferacji i aktywacji białek przekazujących sygnał i aktywujących transkrypcję (STAT)
US8450337B2 (en) 2008-09-30 2013-05-28 Moleculin, Llc Methods of treating skin disorders with caffeic acid analogs
EP3037421A3 (de) 2008-11-25 2016-11-30 University Of Rochester Mlk-hemmer und verfahren zur verwendung
US20130109687A1 (en) * 2010-04-30 2013-05-02 Gary J. Nabel Methods of treating hiv infection: inhibition of dna dependent protein kinase
US20150104442A1 (en) * 2011-08-15 2015-04-16 King's College London Phosphocofilin: cofilin co-localization intensity as a predictor of metastatic recurrence
US10485800B2 (en) 2012-11-30 2019-11-26 The University Of Rochester Mixed lineage kinase inhibitors for HIV/AIDS therapies
TWI629720B (zh) * 2015-09-30 2018-07-11 東京威力科創股份有限公司 用於濕蝕刻製程之溫度的動態控制之方法及設備
CN106074567A (zh) * 2016-07-05 2016-11-09 湖北医药学院 葫芦素b在制备蛋白磷酸酶2a癌性抑制因子抑制剂中的应用
EP3570824A4 (de) * 2017-01-17 2020-10-07 Bar-Ilan University Zusammensetzungen und verfahren zur kontrolle der aktivierung und funktion von natürlichen killerzellen
WO2019147678A1 (en) * 2018-01-23 2019-08-01 Virongy L.L.C. Cofilin phosphorylation for quantifying cd4 t cell damage and predict cd4 t cell recovery from anti-retroviral therapy
CN110194793B (zh) * 2018-02-26 2020-12-01 中国科学院武汉病毒研究所 一种抑制肌动蛋白重组的多肽及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5932221A (en) * 1997-10-30 1999-08-03 Day; Charles E. Genistin-enriched fraction from soy meal
US7052676B2 (en) * 2000-09-26 2006-05-30 The Regents Of The University Of Michigan Methods for inhibition of HIV replication using a small molecule inhibitor
CN1100564C (zh) * 2001-08-29 2003-02-05 周根发 用于治疗hiv感染的药物、其组合物及其用途
EP1633208A1 (de) * 2003-05-27 2006-03-15 DSM IP Assets B.V. Neue diätetische zusammensetzungen und deren verwendung
EP1542016A1 (de) * 2003-12-11 2005-06-15 Institut Gustave Roussy PUMA, phosphoryliertes p53 und p38 MAPK als Marker für HIV-induzierte Apoptose in zirkulierenden T-Zellen eines infizierten Patienten
WO2005103654A2 (fr) * 2004-04-09 2005-11-03 Bioalliance Pharma Methode d’identification de composes actifs sur la replication du virus hiv.

Also Published As

Publication number Publication date
CA2651317A1 (en) 2007-11-15
WO2007130523A3 (en) 2008-06-19
EP2236620A2 (de) 2010-10-06
EP2021496B1 (de) 2010-08-11
DE602007008398D1 (de) 2010-09-23
EP2236620A3 (de) 2011-05-25
WO2007130523A2 (en) 2007-11-15
EP2021496A2 (de) 2009-02-11
US20080064026A1 (en) 2008-03-13
US7662547B2 (en) 2010-02-16
US20100292181A1 (en) 2010-11-18

Similar Documents

Publication Publication Date Title
ATE477331T1 (de) Verfahren zum nachweis einer hiv-infektion
ATE531820T1 (de) Gesundheitszustandstest
ATE499602T1 (de) Signalprozessierungsschaltkreis mit ionensensitivem feldeffekttransistor sowie verfahren zur überwachung einer eigenschaft einer flüssigkeit
ATE523053T1 (de) Verfahren zur erhöhung der positionsverfügbarkeit
DE602006004916D1 (de) Verfahren zur Erfassung des Sturzes einer Person
ATE448524T1 (de) Verfahren und systeme zur definition, identifikation und erfassung geometrischer eigenschaften
DE602005021684D1 (de) Verfahren zur herstellung von pimecrolimus
ATE537098T1 (de) System und verfahren zur erfassung der position einer aufzugskabine
DE602008003048D1 (de) Verfahren und Vorrichtung zur Vermessung einer Objektoberfläche mittels eines Abstandssensors, der den Brennpunkt misst
DK2310043T3 (da) Von Willebrand faktor eller faktor VII samt von Willebrand faktor til behandling af koagulationsdefekt induceret af trombocythæmmere
DE502005008461D1 (de) Verfahren und laseranordnung mit einer vorrichtung zur zustandserkennung eines optischen elements
ATE446572T1 (de) Verfahren und system zur bereitstellung eines tonsignals mit erweiterter bandbreite
DE602005013633D1 (de) Vorrichtung zur Detektion von atmosphärischer Turbulenz
ATE373858T1 (de) Verfahren und vorrichtung zur verringerung von geräuschbeeinträchtigung eines alternativen sensorsignals während multisensorischer sprachverstärkung
DE602005027919D1 (de) Vorrichtung zur Verhinderung einer lateralen Verschiebung für Stabilisatoren
DE602006009625D1 (de) Vorrichtung zur Messung von Dimensionen und vertikale Säule mit einer solchen Vorrichtung
DE602006017483D1 (de) Vorrichtung zur Ölstandsmessung
DE602005018474D1 (de) Nachweis von hiv-typen und hiv-subtypen
DE502004005365D1 (de) Verfahren zur quantitativen Messung von Ablagerung auf festen Oberflächen
DE502008002117D1 (de) Sensoranordnung zur Erfassung von Objekten
ATE551605T1 (de) Verfahren und vorrichtungen zur erkennung von biofilmen
WO2016141370A3 (en) Methods and compositions for identifying pathogenic vibrio parahaemolyticus
MX2017011512A (es) Metodos de visualizacion de la sensibilidad antimicrobiana de cepas aisladas biologicas.
ATE528650T1 (de) Verfahren zum nachweis und zur diagnose einer infektion mit trypanosoma cruzi
DE50108910D1 (de) Vorrichtung zur erfassung der pmd von optoelektronischen übertragungsstrecken

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties